References to accompany the March 2017 issue of Kai Tiaki Nursing New Zealand

1. Chi, K. (2016). Epidemiology: Rising in the East. Nature.  450: S100-S102.
2. Ng, W., Wong, S. & Ng S. (2016). Changing epidemiological trends of inflammatory bowel disease in Asia. Intestinal Research. 14(2): 111-119.
3. Sheehan, D., Moran, C. & Shanahan, F. (2015). The microbiota in inflammatory bowel disease. Journal of Gastroenterology. 50: 495-507. 
4. Day A., Lemberg, D. & Gearry, R. (2014). Inflammatory bowel disease in Australasian children and adolescents. Gastroenterology Research and Practice. Accessed February 2017. https://www.hindawi.com/journals/grp/2014/703890/
5. Lion, M. et al. (2012). The cost of paediatric and perianal Crohn’s disease in Canterbury, New Zealand. New Zealand Medical Journal. 125(1349): 11-20.
6. GESA: Gastroenterological Society of Australia. (2013). Australian Guidelines for General Practitioners and Physicians: Inflammatory Bowel Disease. (3^rd ed.). Mulgrave VIC: Digestive Health Foundation.
7. NICE: UK National Institute for Health and Care Excellence. (2013). Crohn’s disease: Management. NICE CG152. Accessed February 2017. https://www.nice.org.uk/guidance/CG166/chapter/introduction
8. NICE: UK National Institute for Health and Care Excellence. (2016). Ulcerative colitis: Management. NICE CG166. Accessed February 2017. https://www.nice.org.uk/guidance/CG152/chapter/Recommendations
9. Satour, R. (2006). Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nature Clinical Practice Gastroenterology and Hepatology. 3: 390-407.
10. Walfish, A. & Companioni, R. (2016). Crohn Disease. Merck Manual. Accessed February 2017. http://www.merckmanuals.com/professional/gastrointestinal-disorders/inflammatory-bowel-disease-ibd/crohn-disease
11. Rowe, W. & Lichtenstein, G. (2016). Inflammatory Bowel Disease. Medscape Drugs and Diseases. Accessed February 2017. http://emedicine.medscape.com/article/179037-overview?pa=DuD7krB6zYoQBVz8rSvrO9X5Uc35JSb29ymaqsNZhk4airWjga6gAftVzdnpeAJoJyGvMX%2Fu%2BWdIXoARf%2FT0zw%3D%3D#a2
12. DeWeerdt, S. (2016). Genetics: Clues in the code. Nature. 540: S104-S105.
13. De Souza, H. & Fiocchi, C. (2016). Immunopathogenesis of IBD: current state of the art. Nature Reviews Gastroenterology and Hepatology. 13: 13-27.
14. Perrotta, C. et al. (2015). Five-aminosalicylic acid: an update for the reappraisal of an old drug. Gastroenterology Research and Practice.  Accessed February 2017. https://www.hindawi.com/journals/grp/2015/456895/
15. Zenlea, T. & Peppercorn, M. (2014). Immunosuppressive therapies for inflammatory bowel disease. World Journal of Gastroenterology. 20(12): 3146-3152. 
16. Bertrand, P., Loughman, A. & Jackson, M. (2016). Gut feeling: how your microbiota affects your mood, sleep and stress levels. Accessed February 2017. http://theconversation.com/gut-feeling-how-your-microbiota-affects-your-mood-sleep-and-stress-levels-65107?utm_medium=email&utm_campaign=Latest%20from%20The%20Conversation%20for%20October%2011%202016%20-%205775&utm_content=Latest%20from%20The%20Conversation%20for%20October%2011%202016%20-%205775+CID_fb5dea4f5c79b69ccedfc4f3d035a878&utm_source=campaign_monitor&utm_term=Gut%20feeling%20how%20your%20microbiota%20affects%20your%20mood%20sleep%20and%20stress%20levels
17. Kristensen, N. et al. (2015). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome medicine. 8:52 Accessed February 2017. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-016-0300-5